GS follow link to MSigDB | GS DETAILS | SIZE | ES | NES | NOM p-val | FDR q-val | FWER p-val | RANK AT MAX | LEADING EDGE | |
---|---|---|---|---|---|---|---|---|---|---|
1 | HUMANCYC_GLUCONEOGENESIS | Details ... | 17 | 0.87 | 1.76 | 0.000 | 0.045 | 0.078 | 1055 | tags=41%, list=6%, signal=44% |
2 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Details ... | 16 | 0.86 | 1.72 | 0.002 | 0.050 | 0.162 | 129 | tags=13%, list=1%, signal=13% |
3 | HUMANCYC_GLYCOLYSIS III | Details ... | 21 | 0.78 | 1.64 | 0.002 | 0.179 | 0.617 | 1055 | tags=43%, list=6%, signal=45% |
4 | HUMANCYC_GLYCOLYSIS I | Details ... | 20 | 0.78 | 1.61 | 0.002 | 0.220 | 0.784 | 1055 | tags=45%, list=6%, signal=48% |
5 | HUMANCYC_SERINE-ISOCITRATE LYASE PATHWAY | Details ... | 16 | 0.79 | 1.58 | 0.008 | 0.288 | 0.919 | 1499 | tags=50%, list=8%, signal=54% |
6 | HUMANCYC_SUPERPATHWAY OF N-ACETYLNEURAMINATE DEGRADATION | Details ... | 22 | 0.75 | 1.58 | 0.013 | 0.252 | 0.923 | 1110 | tags=45%, list=6%, signal=48% |
7 | HUMANCYC_SUPERPATHWAY OF GLYCOLYSIS AND ENTNER-DOUDOROFF | Details ... | 22 | 0.73 | 1.56 | 0.009 | 0.291 | 0.971 | 1055 | tags=41%, list=6%, signal=43% |
8 | HUMANCYC_GLYCOLYSIS V | Details ... | 18 | 0.77 | 1.54 | 0.013 | 0.342 | 0.997 | 1055 | tags=44%, list=6%, signal=47% |
9 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Details ... | 14 | 0.79 | 1.52 | 0.016 | 0.389 | 0.999 | 1456 | tags=29%, list=8%, signal=31% |
10 | BIOCARTA_IL 2 SIGNALING PATHWAY | Details ... | 14 | 0.77 | 1.51 | 0.020 | 0.376 | 0.999 | 309 | tags=36%, list=2%, signal=36% |
11 | HUMANCYC_PHOSPHOLIPID BIOSYNTHESIS I | Details ... | 10 | 0.83 | 1.47 | 0.019 | 0.606 | 1.000 | 1726 | tags=50%, list=9%, signal=55% |
12 | NCI_ALPHA-SYNUCLEIN SIGNALING | Details ... | 32 | 0.64 | 1.46 | 0.028 | 0.581 | 1.000 | 1927 | tags=28%, list=10%, signal=31% |
13 | BIOCARTA_IL22 SOLUBLE RECEPTOR SIGNALING PATHWAY | Details ... | 11 | 0.80 | 1.44 | 0.037 | 0.646 | 1.000 | 1168 | tags=36%, list=6%, signal=39% |
14 | HUMANCYC_DE NOVO BIOSYNTHESIS OF PYRIMIDINE RIBONUCLEOTIDES | Details ... | 11 | 0.79 | 1.43 | 0.037 | 0.656 | 1.000 | 1525 | tags=55%, list=8%, signal=59% |
15 | REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS | Details ... | 19 | 0.69 | 1.43 | 0.043 | 0.629 | 1.000 | 3205 | tags=42%, list=17%, signal=51% |
16 | INOH_NEGATIVE REGULATION OF (G ALPHA GDP-GTP EXCHANGE SIGNALING) | Details ... | 16 | 0.72 | 1.43 | 0.066 | 0.605 | 1.000 | 3029 | tags=31%, list=16%, signal=37% |
17 | INOH_NEGATIVE REGULATION OF (G ALPHA S GDP-GTP EXCHANGE SIGNALING) | Details ... | 16 | 0.72 | 1.43 | 0.049 | 0.573 | 1.000 | 3029 | tags=31%, list=16%, signal=37% |
18 | INOH_[NEGATIVE REGULATION OF (G ALPHA S GDP-GTP EXCHANGE SIGNALING) | Details ... | 17 | 0.71 | 1.43 | 0.069 | 0.549 | 1.000 | 3029 | tags=29%, list=16%, signal=35% |
19 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Details ... | 19 | 0.69 | 1.43 | 0.067 | 0.529 | 1.000 | 3205 | tags=42%, list=17%, signal=51% |
20 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Details ... | 12 | 0.76 | 1.41 | 0.047 | 0.569 | 1.000 | 2485 | tags=17%, list=13%, signal=19% |
21 | INOH_GROWTH HORMONE SIGNALING PATHWAY(JAK2 STAT5) | 10 | 0.79 | 1.41 | 0.058 | 0.547 | 1.000 | 210 | tags=10%, list=1%, signal=10% | |
22 | INOH_NEGATIVE REGULATION OF (G ALPHA I GDP-GTP EXCHANGE SIGNALING) | 16 | 0.72 | 1.41 | 0.055 | 0.537 | 1.000 | 3029 | tags=31%, list=16%, signal=37% | |
23 | REACTOME_PHASE_II_CONJUGATION | 17 | 0.68 | 1.39 | 0.067 | 0.582 | 1.000 | 1233 | tags=18%, list=7%, signal=19% | |
24 | NCI_SIGNALING EVENTS MEDIATED BY HDAC CLASS III | 30 | 0.62 | 1.39 | 0.043 | 0.558 | 1.000 | 1895 | tags=47%, list=10%, signal=52% | |
25 | REACTOME_GLUCONEOGENESIS | 11 | 0.76 | 1.39 | 0.071 | 0.564 | 1.000 | 1055 | tags=45%, list=6%, signal=48% | |
26 | NCI_SIGNALING EVENTS MEDIATED BY PTP1B | 46 | 0.57 | 1.38 | 0.044 | 0.560 | 1.000 | 2337 | tags=24%, list=13%, signal=27% | |
27 | NCI_VISUAL SIGNAL TRANSDUCTION: CONES | 18 | 0.68 | 1.38 | 0.090 | 0.580 | 1.000 | 50 | tags=6%, list=0%, signal=6% | |
28 | REACTOME_CLASS_A_1__RHODOPSIN_LIKE_RECEPTORS_ | 93 | 0.50 | 1.36 | 0.024 | 0.656 | 1.000 | 3095 | tags=14%, list=17%, signal=17% | |
29 | BIOCARTA_CLASSICAL COMPLEMENT PATHWAY | 10 | 0.76 | 1.35 | 0.106 | 0.648 | 1.000 | 1806 | tags=20%, list=10%, signal=22% | |
30 | REACTOME_INORGANIC_CATION_ANION_SLC_TRANSPORTERS | 12 | 0.72 | 1.35 | 0.104 | 0.661 | 1.000 | 59 | tags=8%, list=0%, signal=8% | |
31 | INOH_GENE EXPRESSION OF SOCS1 BY STAT DIMER | 30 | 0.59 | 1.34 | 0.079 | 0.649 | 1.000 | 3139 | tags=40%, list=17%, signal=48% | |
32 | HUMANCYC_TRIACYLGLYCEROL BIOSYNTHESIS | 11 | 0.74 | 1.34 | 0.099 | 0.636 | 1.000 | 1726 | tags=45%, list=9%, signal=50% | |
33 | HUMANCYC_ENTNER-DOUDOROFF PATHWAY II (NON-PHOSPHORYLATIVE) | 12 | 0.72 | 1.34 | 0.112 | 0.632 | 1.000 | 1833 | tags=33%, list=10%, signal=37% | |
34 | NCI_SYNDECAN-3-MEDIATED SIGNALING EVENTS | 13 | 0.71 | 1.33 | 0.118 | 0.659 | 1.000 | 811 | tags=15%, list=4%, signal=16% | |
35 | REACTOME_EXOCYTOSIS_OF_ALPHA_GRANULE_ | 40 | 0.56 | 1.33 | 0.067 | 0.650 | 1.000 | 1928 | tags=13%, list=10%, signal=14% | |
36 | BIOCARTA_EPO SIGNALING PATHWAY | 11 | 0.74 | 1.32 | 0.131 | 0.641 | 1.000 | 340 | tags=27%, list=2%, signal=28% | |
37 | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 10 | 0.74 | 1.32 | 0.096 | 0.625 | 1.000 | 1806 | tags=20%, list=10%, signal=22% | |
38 | BIOCARTA_DOWNREGULATED OF MTA-3 IN ER-NEGATIVE BREAST TUMORS | 18 | 0.67 | 1.32 | 0.113 | 0.614 | 1.000 | 1535 | tags=33%, list=8%, signal=36% | |
39 | INOH_JAK DEGRADATION SIGNALING | 24 | 0.61 | 1.32 | 0.128 | 0.615 | 1.000 | 3139 | tags=46%, list=17%, signal=55% | |
40 | INOH_NEGATIVE FEEDBACK REGULATION OF JAK STAT PATHWAY BY (JAK DEGRADATION SIGNALING) | 30 | 0.59 | 1.32 | 0.118 | 0.612 | 1.000 | 3139 | tags=40%, list=17%, signal=48% | |
41 | REACTOME_PHASE_1_FUNCTIONALIZATION | 10 | 0.75 | 1.31 | 0.123 | 0.607 | 1.000 | 546 | tags=20%, list=3%, signal=21% | |
42 | REACTOME_COMPLEMENT_CASCADE | 14 | 0.70 | 1.31 | 0.129 | 0.594 | 1.000 | 1806 | tags=14%, list=10%, signal=16% | |
43 | REACTOME_RAS_ACTIVATION_UOPN_CA2__INFUX_THROUGH_NMDA_RECEPTOR | 10 | 0.75 | 1.31 | 0.128 | 0.580 | 1.000 | 1292 | tags=20%, list=7%, signal=21% | |
44 | INOH_NOTCH SECRETORY PATHWAY (MAMMAL) | 22 | 0.62 | 1.31 | 0.101 | 0.584 | 1.000 | 610 | tags=32%, list=3%, signal=33% | |
45 | INOH_MAMMALIAN NOTCH SIGNALING PATHWAY | 22 | 0.62 | 1.30 | 0.118 | 0.616 | 1.000 | 610 | tags=32%, list=3%, signal=33% | |
46 | INOH_CANONICAL NOTCH SIGNALING PATHWAY | 26 | 0.59 | 1.30 | 0.117 | 0.609 | 1.000 | 383 | tags=23%, list=2%, signal=24% | |
47 | INOH_NOTCH SECRETORY PATHWAY | 26 | 0.59 | 1.29 | 0.128 | 0.607 | 1.000 | 383 | tags=23%, list=2%, signal=24% | |
48 | REACTOME_BIOLOGICAL_OXIDATIONS | 46 | 0.52 | 1.28 | 0.099 | 0.647 | 1.000 | 1233 | tags=11%, list=7%, signal=12% | |
49 | HUMANCYC_ISOLEUCINE DEGRADATION III | 13 | 0.67 | 1.28 | 0.149 | 0.639 | 1.000 | 808 | tags=31%, list=4%, signal=32% | |
50 | HUMANCYC_SUPERPATHWAY OF GLYCOLYSIS, PYRUVATE DEHYDROGENASE, TCA, AND GLYOXYLATE BYPASS | 39 | 0.53 | 1.27 | 0.108 | 0.663 | 1.000 | 2435 | tags=36%, list=13%, signal=41% | |
51 | INOH_NEGATIVE FEEDBACK REGULATION OF JAK STAT PATHWAY BY (CYTOKINE RECEPTOR DEGRADATION SIGNALING) | 26 | 0.58 | 1.26 | 0.148 | 0.673 | 1.000 | 3139 | tags=42%, list=17%, signal=51% | |
52 | BIOCARTA_IL 4 SIGNALING PATHWAY | 11 | 0.69 | 1.26 | 0.198 | 0.683 | 1.000 | 449 | tags=27%, list=2%, signal=28% | |
53 | INOH_GENE EXPRESSION OF SOCS3 BY STAT DIMER | 26 | 0.58 | 1.25 | 0.162 | 0.709 | 1.000 | 3139 | tags=42%, list=17%, signal=51% | |
54 | BIOCARTA_MULTIPLE ANTIAPOPTOTIC PATHWAYS FROM IGF-1R SIGNALING LEAD TO BAD PHOSPHORYLATION | 13 | 0.65 | 1.25 | 0.178 | 0.696 | 1.000 | 236 | tags=23%, list=1%, signal=23% | |
55 | HUMANCYC_FATTY ACID BETA-OXIDATION II (CORE PATHWAY) | 16 | 0.63 | 1.25 | 0.197 | 0.695 | 1.000 | 3135 | tags=38%, list=17%, signal=45% | |
56 | BIOCARTA_IL 3 SIGNALING PATHWAY | 11 | 0.69 | 1.24 | 0.214 | 0.698 | 1.000 | 340 | tags=27%, list=2%, signal=28% | |
57 | HUMANCYC_NAD/NADH PHOSPHORYLATION AND DEPHOSPHORYLATION | 30 | 0.55 | 1.24 | 0.141 | 0.692 | 1.000 | 2886 | tags=40%, list=16%, signal=47% | |
58 | INOH_CYTOKINE RECEPTOR DEGRADATION SIGNALING | 20 | 0.59 | 1.23 | 0.181 | 0.710 | 1.000 | 3139 | tags=50%, list=17%, signal=60% | |
59 | REACTOME_DIABETES_PATHWAYS | 159 | 0.42 | 1.23 | 0.078 | 0.710 | 1.000 | 2968 | tags=31%, list=16%, signal=37% | |
60 | REACTOME_MUSCLE_CONTRACTION | 25 | 0.56 | 1.22 | 0.183 | 0.723 | 1.000 | 1456 | tags=20%, list=8%, signal=22% | |
61 | BIOCARTA_IL-7 SIGNAL TRANSDUCTION | 14 | 0.63 | 1.21 | 0.217 | 0.743 | 1.000 | 1591 | tags=29%, list=9%, signal=31% | |
62 | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 22 | 0.57 | 1.21 | 0.190 | 0.739 | 1.000 | 2459 | tags=23%, list=13%, signal=26% | |
63 | NETPATH_IL2 | 61 | 0.47 | 1.20 | 0.157 | 0.771 | 1.000 | 1591 | tags=20%, list=9%, signal=21% | |
64 | REACTOME_PLATELET_DEGRANULATION_ | 42 | 0.50 | 1.20 | 0.164 | 0.766 | 1.000 | 1928 | tags=12%, list=10%, signal=13% | |
65 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 10 | 0.65 | 1.20 | 0.235 | 0.770 | 1.000 | 1092 | tags=10%, list=6%, signal=11% | |
66 | REACTOME_ELECTRON_TRANSPORT_CHAIN | 53 | 0.48 | 1.20 | 0.168 | 0.763 | 1.000 | 2886 | tags=45%, list=16%, signal=53% | |
67 | BIOCARTA_STRESS INDUCTION OF HSP REGULATION | 14 | 0.62 | 1.19 | 0.224 | 0.766 | 1.000 | 926 | tags=21%, list=5%, signal=23% | |
68 | REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES | 64 | 0.46 | 1.19 | 0.169 | 0.761 | 1.000 | 3497 | tags=27%, list=19%, signal=33% | |
69 | BIOCARTA_EICOSANOID METABOLISM | 19 | 0.58 | 1.18 | 0.242 | 0.786 | 1.000 | 2765 | tags=26%, list=15%, signal=31% | |
70 | BIOCARTA_ACTIVATION OF PKC THROUGH G-PROTEIN COUPLED RECEPTORS | 10 | 0.66 | 1.18 | 0.281 | 0.776 | 1.000 | 3890 | tags=40%, list=21%, signal=51% | |
71 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 25 | 0.54 | 1.17 | 0.236 | 0.806 | 1.000 | 2032 | tags=36%, list=11%, signal=40% | |
72 | HUMANCYC_SUPERPATHWAY OF CITRULLINE METABOLISM | 11 | 0.64 | 1.17 | 0.283 | 0.810 | 1.000 | 2579 | tags=36%, list=14%, signal=42% | |
73 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA__ | 44 | 0.49 | 1.16 | 0.225 | 0.806 | 1.000 | 1928 | tags=11%, list=10%, signal=13% | |
74 | BIOCARTA_GROWTH HORMONE SIGNALING PATHWAY | 17 | 0.56 | 1.16 | 0.250 | 0.808 | 1.000 | 426 | tags=18%, list=2%, signal=18% | |
75 | INOH_TGF BETA RECEPTOR I DEGRADATION SIGNALING | 25 | 0.54 | 1.16 | 0.233 | 0.807 | 1.000 | 3139 | tags=36%, list=17%, signal=43% | |
76 | BIOCARTA_ROLES OF FL ARRESTIN DEPENDENT RECRUITMENT OF SRC KINASES IN GPCR SIGNALING | 32 | 0.51 | 1.16 | 0.251 | 0.799 | 1.000 | 1528 | tags=22%, list=8%, signal=24% | |
77 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR__IGF__ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS__IGFBPS_ | 12 | 0.61 | 1.16 | 0.287 | 0.793 | 1.000 | 4093 | tags=50%, list=22%, signal=64% | |
78 | REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | 14 | 0.61 | 1.15 | 0.291 | 0.790 | 1.000 | 3876 | tags=64%, list=21%, signal=81% | |
79 | HUMANCYC_PHOSPHOLIPID BIOSYNTHESIS II | 22 | 0.55 | 1.15 | 0.291 | 0.788 | 1.000 | 1726 | tags=27%, list=9%, signal=30% | |
80 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 12 | 0.63 | 1.15 | 0.295 | 0.789 | 1.000 | 1531 | tags=50%, list=8%, signal=54% | |
81 | BIOCARTA_CALCIUM SIGNALING BY HBX OF HEPATITIS B VIRUS | 15 | 0.59 | 1.15 | 0.297 | 0.789 | 1.000 | 236 | tags=20%, list=1%, signal=20% | |
82 | REACTOME_GLUCOSE_REGULATION_OF_INSULIN_SECRETION | 90 | 0.42 | 1.13 | 0.197 | 0.835 | 1.000 | 2886 | tags=38%, list=16%, signal=44% | |
83 | BIOCARTA_RAS-INDEPENDENT PATHWAY IN NK CELL-MEDIATED CYTOTOXICITY | 19 | 0.55 | 1.13 | 0.286 | 0.827 | 1.000 | 340 | tags=16%, list=2%, signal=16% | |
84 | BIOCARTA_MELANOCYTE DEVELOPMENT AND PIGMENTATION PATHWAY | 12 | 0.62 | 1.13 | 0.322 | 0.819 | 1.000 | 426 | tags=25%, list=2%, signal=26% | |
85 | REACTOME_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 11 | 0.61 | 1.13 | 0.325 | 0.819 | 1.000 | 2459 | tags=27%, list=13%, signal=31% | |
86 | INOH_TGF BETA RECEPTOR COMPLEX DEGRADATION SIGNALING | 29 | 0.50 | 1.13 | 0.255 | 0.809 | 1.000 | 3139 | tags=34%, list=17%, signal=41% | |
87 | NETPATH_CD40 | 30 | 0.50 | 1.13 | 0.295 | 0.805 | 1.000 | 1179 | tags=23%, list=6%, signal=25% | |
88 | NCI_AMB2 INTEGRIN SIGNALING | 48 | 0.46 | 1.12 | 0.250 | 0.804 | 1.000 | 2372 | tags=21%, list=13%, signal=24% | |
89 | REACTOME_METABOLISM_OF_BILE_ACIDS_AND_BILE_SALTS | 14 | 0.59 | 1.12 | 0.313 | 0.800 | 1.000 | 1092 | tags=7%, list=6%, signal=8% | |
90 | BIOCARTA_IL-2 RECEPTOR BETA CHAIN IN T CELL ACTIVATION | 48 | 0.45 | 1.12 | 0.276 | 0.796 | 1.000 | 353 | tags=19%, list=2%, signal=19% | |
91 | BIOCARTA_ROLE OF ERBB2 IN SIGNAL TRANSDUCTION AND ONCOLOGY | 27 | 0.51 | 1.12 | 0.284 | 0.790 | 1.000 | 348 | tags=15%, list=2%, signal=15% | |
92 | HUMANCYC_TRIACYLGLYCEROL DEGRADATION | 12 | 0.61 | 1.12 | 0.320 | 0.782 | 1.000 | 3832 | tags=25%, list=21%, signal=31% | |
93 | NETPATH_TCR | 105 | 0.41 | 1.12 | 0.208 | 0.791 | 1.000 | 1785 | tags=23%, list=10%, signal=25% | |
94 | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 57 | 0.44 | 1.12 | 0.247 | 0.783 | 1.000 | 3497 | tags=26%, list=19%, signal=32% | |
95 | REACTOME_ATP_FORMATION | 15 | 0.57 | 1.11 | 0.312 | 0.776 | 1.000 | 2502 | tags=40%, list=13%, signal=46% | |
96 | BIOCARTA_ROLE OF ERK5 IN NEURONAL SURVIVAL PATHWAY | 24 | 0.52 | 1.11 | 0.311 | 0.791 | 1.000 | 426 | tags=17%, list=2%, signal=17% | |
97 | REACTOME_REGULATION_OF_INSULIN_SECRETION | 101 | 0.40 | 1.11 | 0.234 | 0.785 | 1.000 | 2886 | tags=36%, list=16%, signal=42% | |
98 | NCI_IL12 SIGNALING MEDIATED BY STAT4 | 28 | 0.49 | 1.11 | 0.290 | 0.778 | 1.000 | 2125 | tags=29%, list=11%, signal=32% | |
99 | HUMANCYC_COLANIC ACID BUILDING BLOCKS BIOSYNTHESIS | 10 | 0.63 | 1.11 | 0.375 | 0.770 | 1.000 | 762 | tags=20%, list=4%, signal=21% | |
100 | NCI_PRESENILIN ACTION IN NOTCH AND WNT SIGNALING | 40 | 0.46 | 1.11 | 0.280 | 0.765 | 1.000 | 580 | tags=13%, list=3%, signal=13% | |
101 | REACTOME_METABOLISM_OF_NUCLEOTIDES | 62 | 0.44 | 1.11 | 0.257 | 0.761 | 1.000 | 2582 | tags=32%, list=14%, signal=37% | |
102 | BIOCARTA_FL-ARRESTINS IN GPCR DESENSITIZATION | 26 | 0.50 | 1.10 | 0.313 | 0.770 | 1.000 | 2455 | tags=27%, list=13%, signal=31% | |
103 | HUMANCYC_GLUTATHIONE-MEDIATED DETOXIFICATION | 16 | 0.56 | 1.10 | 0.336 | 0.763 | 1.000 | 1233 | tags=25%, list=7%, signal=27% | |
104 | REACTOME_SIGNALING_BY_GPCR | 141 | 0.39 | 1.10 | 0.221 | 0.765 | 1.000 | 3095 | tags=13%, list=17%, signal=15% | |
105 | NCI_THROMBOXANE A2 RECEPTOR SIGNALING | 50 | 0.45 | 1.10 | 0.303 | 0.759 | 1.000 | 722 | tags=18%, list=4%, signal=19% | |
106 | BIOCARTA_LCK AND FYN TYROSINE KINASES IN INITIATION OF TCR ACTIVATION | 10 | 0.62 | 1.10 | 0.376 | 0.756 | 1.000 | 2032 | tags=60%, list=11%, signal=67% | |
107 | HUMANCYC_GLYCINE BETAINE DEGRADATION | 10 | 0.63 | 1.09 | 0.368 | 0.750 | 1.000 | 2759 | tags=30%, list=15%, signal=35% | |
108 | INOH_B CELL RECEPTOR SIGNALING PATHWAY | 68 | 0.42 | 1.09 | 0.277 | 0.754 | 1.000 | 1591 | tags=22%, list=9%, signal=24% | |
109 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | 12 | 0.60 | 1.09 | 0.358 | 0.749 | 1.000 | 2458 | tags=42%, list=13%, signal=48% | |
110 | REACTOME_CLATHRIN_DERIVED_VESICLE_BUDDING | 15 | 0.56 | 1.09 | 0.347 | 0.746 | 1.000 | 1615 | tags=40%, list=9%, signal=44% | |
111 | NCI_IL4-MEDIATED SIGNALING EVENTS | 58 | 0.43 | 1.09 | 0.295 | 0.752 | 1.000 | 1757 | tags=17%, list=9%, signal=19% | |
112 | BIOCARTA_BIOACTIVE PEPTIDE INDUCED SIGNALING PATHWAY | 32 | 0.47 | 1.08 | 0.363 | 0.765 | 1.000 | 463 | tags=16%, list=2%, signal=16% | |
113 | REACTOME_SEMAPHORIN_INTERACTIONS | 30 | 0.48 | 1.08 | 0.332 | 0.759 | 1.000 | 1531 | tags=23%, list=8%, signal=25% | |
114 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 53 | 0.43 | 1.08 | 0.308 | 0.753 | 1.000 | 3442 | tags=15%, list=18%, signal=18% | |
115 | CELLMAP_KITRECEPTOR | 49 | 0.44 | 1.08 | 0.333 | 0.757 | 1.000 | 932 | tags=14%, list=5%, signal=15% | |
116 | NCI_IL2 SIGNALING EVENTS MEDIATED BY STAT5 | 29 | 0.48 | 1.07 | 0.363 | 0.758 | 1.000 | 1591 | tags=17%, list=9%, signal=19% | |
117 | REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING | 15 | 0.56 | 1.07 | 0.376 | 0.756 | 1.000 | 1615 | tags=40%, list=9%, signal=44% | |
118 | REACTOME_METABOLISM_OF_AMINO_ACIDS | 106 | 0.39 | 1.07 | 0.306 | 0.766 | 1.000 | 3242 | tags=31%, list=17%, signal=37% | |
119 | NCI_FGF SIGNALING PATHWAY | 43 | 0.44 | 1.06 | 0.354 | 0.775 | 1.000 | 832 | tags=12%, list=4%, signal=12% | |
120 | REACTOME_METABOLISM_OF_CARBOHYDRATES | 70 | 0.41 | 1.06 | 0.355 | 0.782 | 1.000 | 1055 | tags=16%, list=6%, signal=17% | |
121 | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 109 | 0.38 | 1.05 | 0.350 | 0.810 | 1.000 | 2886 | tags=33%, list=16%, signal=39% | |
122 | NETPATH_IFN-ALPHA | 43 | 0.43 | 1.04 | 0.385 | 0.825 | 1.000 | 1591 | tags=26%, list=9%, signal=28% | |
123 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | 18 | 0.52 | 1.03 | 0.430 | 0.833 | 1.000 | 3242 | tags=33%, list=17%, signal=40% | |
124 | BIOCARTA_CASPASE CASCADE IN APOPTOSIS | 21 | 0.49 | 1.03 | 0.385 | 0.835 | 1.000 | 2386 | tags=33%, list=13%, signal=38% | |
125 | NCI_IL27-MEDIATED SIGNALING EVENTS | 26 | 0.47 | 1.03 | 0.414 | 0.837 | 1.000 | 1336 | tags=15%, list=7%, signal=17% | |
126 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | 12 | 0.55 | 1.03 | 0.436 | 0.837 | 1.000 | 1615 | tags=42%, list=9%, signal=46% | |
127 | BIOCARTA_TPO SIGNALING PATHWAY | 22 | 0.49 | 1.03 | 0.408 | 0.831 | 1.000 | 236 | tags=14%, list=1%, signal=14% | |
128 | BIOCARTA_IL 6 SIGNALING PATHWAY | 13 | 0.55 | 1.02 | 0.458 | 0.844 | 1.000 | 183 | tags=15%, list=1%, signal=16% | |
129 | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 22 | 0.48 | 1.02 | 0.413 | 0.843 | 1.000 | 2125 | tags=32%, list=11%, signal=36% | |
130 | HUMANCYC_SALVAGE PATHWAYS OF PURINE AND PYRIMIDINE NUCLEOTIDES | 19 | 0.50 | 1.01 | 0.437 | 0.852 | 1.000 | 3225 | tags=37%, list=17%, signal=45% | |
131 | BIOCARTA_INDUCTION OF APOPTOSIS THROUGH DR3 AND DR4/5 DEATH RECEPTORS | 19 | 0.49 | 1.01 | 0.432 | 0.850 | 1.000 | 3144 | tags=37%, list=17%, signal=44% | |
132 | REACTOME_REGULATORY_RNA_PATHWAYS | 10 | 0.56 | 1.01 | 0.458 | 0.858 | 1.000 | 3766 | tags=50%, list=20%, signal=63% | |
133 | REACTOME_INSULIN_SYNTHESIS_AND_SECRETION | 66 | 0.39 | 1.00 | 0.431 | 0.859 | 1.000 | 2968 | tags=26%, list=16%, signal=31% | |
134 | BIOCARTA_INTRINSIC PROTHROMBIN ACTIVATION PATHWAY | 22 | 0.47 | 1.00 | 0.467 | 0.875 | 1.000 | 3725 | tags=18%, list=20%, signal=23% | |
135 | BIOCARTA_ERK1/ERK2 MAPK SIGNALING PATHWAY | 20 | 0.47 | 1.00 | 0.473 | 0.869 | 1.000 | 426 | tags=15%, list=2%, signal=15% | |
136 | NCI_DOWNSTREAM SIGNALING IN NAÔVE CD8+ T CELLS | 48 | 0.41 | 1.00 | 0.450 | 0.865 | 1.000 | 2032 | tags=25%, list=11%, signal=28% | |
137 | BIOCARTA_RHO CELL MOTILITY SIGNALING PATHWAY | 24 | 0.46 | 0.98 | 0.496 | 0.905 | 1.000 | 2882 | tags=33%, list=15%, signal=39% | |
138 | NCI_TCR SIGNALING IN NAÔVE CD8+ T CELLS | 108 | 0.36 | 0.98 | 0.498 | 0.902 | 1.000 | 2125 | tags=22%, list=11%, signal=25% | |
139 | NETPATH_IL-7 | 16 | 0.50 | 0.98 | 0.495 | 0.902 | 1.000 | 216 | tags=19%, list=1%, signal=19% | |
140 | REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION | 47 | 0.39 | 0.98 | 0.474 | 0.896 | 1.000 | 2909 | tags=26%, list=16%, signal=30% | |
141 | NCI_ARF6 DOWNSTREAM PATHWAY | 25 | 0.46 | 0.98 | 0.495 | 0.890 | 1.000 | 2533 | tags=40%, list=14%, signal=46% | |
142 | REACTOME_HEMOSTASIS | 147 | 0.35 | 0.98 | 0.505 | 0.888 | 1.000 | 1928 | tags=14%, list=10%, signal=15% | |
143 | REACTOME_PEPTIDE_CHAIN_ELONGATION | 45 | 0.40 | 0.97 | 0.490 | 0.889 | 1.000 | 2777 | tags=24%, list=15%, signal=29% | |
144 | REACTOME_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS | 44 | 0.40 | 0.97 | 0.500 | 0.893 | 1.000 | 2777 | tags=25%, list=15%, signal=29% | |
145 | NCI_CALCINEURIN-REGULATED NFAT-DEPENDENT TRANSCRIPTION IN LYMPHOCYTES | 43 | 0.40 | 0.97 | 0.512 | 0.894 | 1.000 | 1737 | tags=16%, list=9%, signal=18% | |
146 | NCI_PDGFR-BETA SIGNALING PATHWAY | 51 | 0.39 | 0.97 | 0.520 | 0.889 | 1.000 | 2045 | tags=16%, list=11%, signal=18% | |
147 | REACTOME_GLUCOSE_METABOLISM | 54 | 0.39 | 0.97 | 0.505 | 0.883 | 1.000 | 1055 | tags=15%, list=6%, signal=16% | |
148 | NETPATH_NGF | 45 | 0.39 | 0.96 | 0.510 | 0.899 | 1.000 | 932 | tags=18%, list=5%, signal=19% | |
149 | NCI_EPO SIGNALING PATHWAY | 32 | 0.42 | 0.96 | 0.502 | 0.896 | 1.000 | 736 | tags=16%, list=4%, signal=16% | |
150 | REACTOME_MEMBRANE_TRAFFICKING | 26 | 0.43 | 0.96 | 0.524 | 0.900 | 1.000 | 1615 | tags=35%, list=9%, signal=38% | |
151 | NCI_IL12-MEDIATED SIGNALING EVENTS | 104 | 0.35 | 0.95 | 0.533 | 0.896 | 1.000 | 2827 | tags=24%, list=15%, signal=28% | |
152 | NCI_S1P1 PATHWAY | 64 | 0.37 | 0.95 | 0.559 | 0.893 | 1.000 | 876 | tags=11%, list=5%, signal=11% | |
153 | BIOCARTA_VISUAL SIGNAL TRANSDUCTION | 13 | 0.50 | 0.95 | 0.524 | 0.894 | 1.000 | 50 | tags=8%, list=0%, signal=8% | |
154 | NCI_CALCIUM SIGNALING IN THE CD4+ TCR PATHWAY | 22 | 0.44 | 0.95 | 0.504 | 0.898 | 1.000 | 1737 | tags=18%, list=9%, signal=20% | |
155 | INOH_ERK CASCADE | 12 | 0.51 | 0.95 | 0.569 | 0.897 | 1.000 | 576 | tags=25%, list=3%, signal=26% | |
156 | BIOCARTA_PHOSPHORYLATION OF MEK1 BY CDK5/P35 DOWN REGULATES THE MAP KINASE PATHWAY | 13 | 0.50 | 0.94 | 0.541 | 0.897 | 1.000 | 861 | tags=23%, list=5%, signal=24% | |
157 | REACTOME_PURINE_SALVAGE_REACTIONS | 10 | 0.54 | 0.94 | 0.586 | 0.897 | 1.000 | 3049 | tags=40%, list=16%, signal=48% | |
158 | NCI_ARF1 PATHWAY | 13 | 0.50 | 0.94 | 0.561 | 0.894 | 1.000 | 1684 | tags=46%, list=9%, signal=51% | |
159 | NCI_TRK RECEPTOR SIGNALING MEDIATED BY THE MAPK PATHWAY | 31 | 0.41 | 0.94 | 0.543 | 0.889 | 1.000 | 861 | tags=19%, list=5%, signal=20% | |
160 | BIOCARTA_TREFOIL FACTORS INITIATE MUCOSAL HEALING | 34 | 0.41 | 0.94 | 0.546 | 0.885 | 1.000 | 439 | tags=15%, list=2%, signal=15% | |
161 | INOH_SNON DEGRADATION SIGNALING | 25 | 0.44 | 0.94 | 0.549 | 0.886 | 1.000 | 3139 | tags=40%, list=17%, signal=48% | |
162 | INOH_JAK-STAT PATHWAY AND REGULATION PATHWAY | 196 | 0.32 | 0.94 | 0.666 | 0.889 | 1.000 | 2146 | tags=16%, list=12%, signal=18% | |
163 | HUMANCYC_SALVAGE PATHWAYS OF PYRIMIDINE RIBONUCLEOTIDES | 12 | 0.51 | 0.93 | 0.573 | 0.885 | 1.000 | 3001 | tags=25%, list=16%, signal=30% | |
164 | HUMANCYC_SUPERPATHWAY OF HISTIDINE, PURINE, AND PYRIMIDINE BIOSYNTHESIS | 33 | 0.41 | 0.93 | 0.546 | 0.881 | 1.000 | 2502 | tags=30%, list=13%, signal=35% | |
165 | NCI_SYNDECAN-2-MEDIATED SIGNALING EVENTS | 68 | 0.36 | 0.93 | 0.591 | 0.889 | 1.000 | 2337 | tags=18%, list=13%, signal=20% | |
166 | REACTOME_PHASE_1___FUNCTIONALIZATION_OF_COMPOUNDS | 29 | 0.42 | 0.93 | 0.567 | 0.896 | 1.000 | 546 | tags=7%, list=3%, signal=7% | |
167 | REACTOME_PAUSING_AND_RECOVERY_OF_ELONGATION | 20 | 0.44 | 0.92 | 0.568 | 0.897 | 1.000 | 4042 | tags=65%, list=22%, signal=83% | |
168 | INOH_DROSOPHILA TOLL-LIKE RECEPTOR SIGNALING | 193 | 0.31 | 0.92 | 0.696 | 0.893 | 1.000 | 2531 | tags=18%, list=14%, signal=21% | |
169 | NCI_SIGNALING EVENTS MEDIATED BY STEM CELL FACTOR RECEPTOR (C-KIT) | 48 | 0.38 | 0.92 | 0.601 | 0.888 | 1.000 | 715 | tags=13%, list=4%, signal=13% | |
170 | REACTOME_PYRIMIDINE_METABOLISM | 17 | 0.47 | 0.92 | 0.606 | 0.884 | 1.000 | 1051 | tags=29%, list=6%, signal=31% | |
171 | NCI_EPHA FORWARD SIGNALING | 30 | 0.41 | 0.92 | 0.583 | 0.879 | 1.000 | 2337 | tags=17%, list=13%, signal=19% | |
172 | REACTOME_CREB_PHOPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS | 15 | 0.47 | 0.92 | 0.563 | 0.876 | 1.000 | 1292 | tags=20%, list=7%, signal=21% | |
173 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | 12 | 0.49 | 0.92 | 0.573 | 0.875 | 1.000 | 46 | tags=8%, list=0%, signal=8% | |
174 | REACTOME_HIV_1_ELONGATION_ARREST_AND_RECOVERY | 20 | 0.44 | 0.92 | 0.583 | 0.872 | 1.000 | 4042 | tags=65%, list=22%, signal=83% | |
175 | NCI_SIGNALING EVENTS MEDIATED BY HDAC CLASS I | 90 | 0.34 | 0.92 | 0.649 | 0.871 | 1.000 | 2827 | tags=33%, list=15%, signal=39% | |
176 | REACTOME_TAT_MEDIATED_HIV_1_ELONGATION_ARREST_AND_RECOVERY_ | 19 | 0.44 | 0.91 | 0.589 | 0.883 | 1.000 | 4042 | tags=68%, list=22%, signal=87% | |
177 | BIOCARTA_CADMIUM INDUCES DNA SYNTHESIS AND PROLIFERATION IN MACROPHAGES | 15 | 0.47 | 0.91 | 0.592 | 0.882 | 1.000 | 236 | tags=13%, list=1%, signal=13% | |
178 | INOH_PHOSPHOLIPASE C GAMMA SIGNALING | 48 | 0.37 | 0.91 | 0.639 | 0.879 | 1.000 | 1652 | tags=27%, list=9%, signal=30% | |
179 | NETPATH_EPO | 39 | 0.39 | 0.91 | 0.604 | 0.875 | 1.000 | 2827 | tags=28%, list=15%, signal=33% | |
180 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | 10 | 0.52 | 0.91 | 0.607 | 0.870 | 1.000 | 560 | tags=20%, list=3%, signal=21% | |
181 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | 20 | 0.44 | 0.91 | 0.609 | 0.866 | 1.000 | 4042 | tags=65%, list=22%, signal=83% | |
182 | REACTOME_PAUSING_AND_RECOVERY_OF_HIV_1_ELONGATION | 20 | 0.44 | 0.90 | 0.619 | 0.872 | 1.000 | 4042 | tags=65%, list=22%, signal=83% | |
183 | INOH_T CELL RECEPTOR SIGNALING (PLC GAMMA, PKC, RAS AND ERK CASCADE) | 32 | 0.40 | 0.90 | 0.613 | 0.868 | 1.000 | 1652 | tags=34%, list=9%, signal=38% | |
184 | REACTOME_PAUSING_AND_RECOVERY_OF_TAT_MEDIATED_HIV_1_ELONGATION | 19 | 0.44 | 0.90 | 0.615 | 0.864 | 1.000 | 4042 | tags=68%, list=22%, signal=87% | |
185 | BIOCARTA_ROLE OF FL-ARRESTINS IN THE ACTIVATION AND TARGETING OF MAP KINASES | 28 | 0.41 | 0.90 | 0.602 | 0.865 | 1.000 | 1528 | tags=18%, list=8%, signal=19% | |
186 | NCI_SIGNALING MEDIATED BY P38-ALPHA AND P38-BETA | 46 | 0.36 | 0.90 | 0.631 | 0.865 | 1.000 | 1179 | tags=11%, list=6%, signal=12% | |
187 | INOH_HETEROTRIMERIC GPCR SIGNALING PATHWAY (THROUGH G ALPHA Q, PLC BETA AND ERK CASCADE) | 185 | 0.31 | 0.90 | 0.754 | 0.861 | 1.000 | 2627 | tags=9%, list=14%, signal=11% | |
188 | BIOCARTA_APOPTOTIC SIGNALING IN RESPONSE TO DNA DAMAGE | 14 | 0.47 | 0.89 | 0.613 | 0.865 | 1.000 | 2149 | tags=29%, list=12%, signal=32% | |
189 | NETPATH_THROMBOPOIETIN | 40 | 0.38 | 0.89 | 0.652 | 0.865 | 1.000 | 1179 | tags=15%, list=6%, signal=16% | |
190 | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 15 | 0.46 | 0.89 | 0.637 | 0.864 | 1.000 | 2293 | tags=20%, list=12%, signal=23% | |
191 | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 41 | 0.37 | 0.89 | 0.657 | 0.861 | 1.000 | 1292 | tags=17%, list=7%, signal=18% | |
192 | BIOCARTA_CORTICOSTEROIDS AND CARDIOPROTECTION | 25 | 0.41 | 0.88 | 0.652 | 0.876 | 1.000 | 2827 | tags=20%, list=15%, signal=24% | |
193 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 16 | 0.45 | 0.88 | 0.646 | 0.883 | 1.000 | 3499 | tags=50%, list=19%, signal=62% | |
194 | NCI_ATYPICAL NF-KAPPAB PATHWAY | 14 | 0.46 | 0.87 | 0.644 | 0.886 | 1.000 | 3229 | tags=36%, list=17%, signal=43% | |
195 | REACTOME_EUKARYOTIC_TRANSLATION_TERMINATION | 46 | 0.36 | 0.87 | 0.695 | 0.890 | 1.000 | 2777 | tags=24%, list=15%, signal=28% | |
196 | BIOCARTA_ROLE OF NICOTINIC ACETYLCHOLINE RECEPTORS IN THE REGULATION OF APOPTOSIS | 17 | 0.44 | 0.87 | 0.634 | 0.888 | 1.000 | 776 | tags=18%, list=4%, signal=18% | |
197 | REACTOME_PURINE_METABOLISM | 39 | 0.37 | 0.87 | 0.703 | 0.888 | 1.000 | 3049 | tags=33%, list=16%, signal=40% | |
198 | REACTOME_SYNAPTIC_TRANSMISSION | 42 | 0.36 | 0.87 | 0.680 | 0.885 | 1.000 | 1292 | tags=17%, list=7%, signal=18% | |
199 | REACTOME_DOWNSTREAM_EVENTS_IN_GPCR_SIGNALING | 20 | 0.42 | 0.86 | 0.657 | 0.891 | 1.000 | 1257 | tags=20%, list=7%, signal=21% | |
200 | BIOCARTA_NERVE GROWTH FACTOR PATHWAY (NGF) | 15 | 0.44 | 0.86 | 0.642 | 0.894 | 1.000 | 236 | tags=13%, list=1%, signal=13% | |
201 | REACTOME_VIRAL_MRNA_TRANSLATION | 46 | 0.35 | 0.86 | 0.742 | 0.898 | 1.000 | 2777 | tags=24%, list=15%, signal=28% | |
202 | NCI_RAS SIGNALING IN THE CD4+ TCR PATHWAY | 32 | 0.38 | 0.86 | 0.716 | 0.895 | 1.000 | 1737 | tags=19%, list=9%, signal=21% | |
203 | REACTOME_ORNITHINE_AND_PROLINE_METABOLISM | 46 | 0.35 | 0.85 | 0.762 | 0.893 | 1.000 | 3189 | tags=37%, list=17%, signal=44% | |
204 | INOH_RAF ACTIVATION SIGNALING (THROUGH GRB2 AND SOS) | 11 | 0.46 | 0.85 | 0.691 | 0.896 | 1.000 | 576 | tags=27%, list=3%, signal=28% | |
205 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | 15 | 0.43 | 0.84 | 0.701 | 0.905 | 1.000 | 683 | tags=33%, list=4%, signal=35% | |
206 | BIOCARTA_CELL CYCLE: G2/M CHECKPOINT | 19 | 0.42 | 0.84 | 0.707 | 0.904 | 1.000 | 1748 | tags=21%, list=9%, signal=23% | |
207 | INOH_T CELL RECEPTOR SIGNALING (PLC GAMMA, PKC, RAS AND IKK-NF-KAPPAB CASCADE) | 26 | 0.38 | 0.84 | 0.718 | 0.915 | 1.000 | 1591 | tags=31%, list=9%, signal=34% | |
208 | BIOCARTA_THE CO-STIMULATORY SIGNAL DURING T-CELL ACTIVATION | 17 | 0.41 | 0.83 | 0.703 | 0.916 | 1.000 | 2125 | tags=35%, list=11%, signal=40% | |
209 | INOH_HETEROTRIMERIC GTP-BINDING PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY (THROUGH G ALPHA I, ADENYLATE CYCLASE AND CAMP) | 175 | 0.28 | 0.83 | 0.952 | 0.922 | 1.000 | 2517 | tags=7%, list=14%, signal=8% | |
210 | INOH_IKK-NF-KAPPAB CASCADE | 12 | 0.45 | 0.83 | 0.692 | 0.922 | 1.000 | 3229 | tags=42%, list=17%, signal=50% | |
211 | NCI_FOXM1 TRANSCRIPTION FACTOR NETWORK | 34 | 0.36 | 0.82 | 0.767 | 0.921 | 1.000 | 1065 | tags=21%, list=6%, signal=22% | |
212 | REACTOME_PURINE_BIOSYNTHESIS | 24 | 0.38 | 0.82 | 0.728 | 0.918 | 1.000 | 2938 | tags=33%, list=16%, signal=40% | |
213 | BIOCARTA_ASPIRIN BLOCKS SIGNALING PATHWAY INVOLVED IN PLATELET ACTIVATION | 16 | 0.41 | 0.82 | 0.715 | 0.914 | 1.000 | 2627 | tags=31%, list=14%, signal=36% | |
214 | BIOCARTA_PROTEIN KINASE A AT THE CENTROSOME | 10 | 0.46 | 0.82 | 0.737 | 0.917 | 1.000 | 1304 | tags=30%, list=7%, signal=32% | |
215 | BIOCARTA_ROLE OF MEF2D IN T-CELL APOPTOSIS | 25 | 0.38 | 0.82 | 0.753 | 0.914 | 1.000 | 2039 | tags=36%, list=11%, signal=40% | |
216 | INOH_HETEROTRIMERIC GPCR SIGNALING PATHWAY (THROUGH G ALPHA I AND PERTUSSIS TOXIN) | 175 | 0.28 | 0.82 | 0.947 | 0.912 | 1.000 | 2517 | tags=7%, list=14%, signal=8% | |
217 | BIOCARTA_ROLE OF EGF RECEPTOR TRANSACTIVATION BY GPCRS IN CARDIAC HYPERTROPHY | 32 | 0.36 | 0.82 | 0.785 | 0.911 | 1.000 | 463 | tags=13%, list=2%, signal=13% | |
218 | INOH_GENE EXPRESSION OF SOCS BY STAT DIMER | 13 | 0.43 | 0.81 | 0.730 | 0.920 | 1.000 | 353 | tags=15%, list=2%, signal=16% | |
219 | BIOCARTA_ERK AND PI-3 KINASE ARE NECESSARY FOR COLLAGEN BINDING IN CORNEAL EPITHELIA | 28 | 0.36 | 0.81 | 0.788 | 0.919 | 1.000 | 2337 | tags=32%, list=13%, signal=37% | |
220 | NCI_IL23-MEDIATED SIGNALING EVENTS | 65 | 0.32 | 0.81 | 0.866 | 0.915 | 1.000 | 2827 | tags=22%, list=15%, signal=25% | |
221 | BIOCARTA_ROLE OF BRCA1 BRCA2 AND ATR IN CANCER SUSCEPTIBILITY | 21 | 0.38 | 0.80 | 0.772 | 0.919 | 1.000 | 1179 | tags=14%, list=6%, signal=15% | |
222 | HUMANCYC_DE NOVO BIOSYNTHESIS OF PYRIMIDINE DEOXYRIBONUCLEOTIDES | 11 | 0.44 | 0.80 | 0.733 | 0.927 | 1.000 | 3172 | tags=45%, list=17%, signal=55% | |
223 | BIOCARTA_IL12 AND STAT4 DEPENDENT SIGNALING PATHWAY IN TH1 DEVELOPMENT | 15 | 0.42 | 0.80 | 0.768 | 0.924 | 1.000 | 1336 | tags=20%, list=7%, signal=22% | |
224 | BIOCARTA_REGULATION OF PGC-1A | 18 | 0.39 | 0.79 | 0.781 | 0.929 | 1.000 | 2039 | tags=28%, list=11%, signal=31% | |
225 | NCI_S1P4 PATHWAY | 11 | 0.44 | 0.79 | 0.763 | 0.925 | 1.000 | 691 | tags=18%, list=4%, signal=19% | |
226 | INOH_HETEROTRIMERIC GPCR SIGNALING PATHWAY (THROUGH G ALPHA S ACS EPAC BRAF AND ERKCASCADE) | 197 | 0.27 | 0.79 | 0.994 | 0.924 | 1.000 | 2268 | tags=7%, list=12%, signal=8% | |
227 | INOH_HETEROTRIMERIC GTP-BINDING PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY (THROUGH_G_ALPHA_S,_CHOLERA_TOXIN,_ADENYLATE_CYCLASE_AND_CAMP) | 179 | 0.27 | 0.79 | 0.989 | 0.924 | 1.000 | 2517 | tags=7%, list=14%, signal=8% | |
228 | BIOCARTA_CCR3 SIGNALING IN EOSINOPHILS | 21 | 0.37 | 0.78 | 0.799 | 0.925 | 1.000 | 1257 | tags=19%, list=7%, signal=20% | |
229 | HUMANCYC_SUPERPATHWAY OF GLYOXYLATE CYCLE | 10 | 0.43 | 0.78 | 0.803 | 0.931 | 1.000 | 3411 | tags=40%, list=18%, signal=49% | |
230 | INOH_PLC BETA SIGNALING | 18 | 0.38 | 0.77 | 0.790 | 0.933 | 1.000 | 1188 | tags=22%, list=6%, signal=24% | |
231 | REACTOME_CELL_JUNCTION_ORGANIZATION | 23 | 0.36 | 0.77 | 0.850 | 0.931 | 1.000 | 2377 | tags=22%, list=13%, signal=25% | |
232 | BIOCARTA_HEMOGLOBINS CHAPERONE | 10 | 0.43 | 0.77 | 0.770 | 0.933 | 1.000 | 3551 | tags=50%, list=19%, signal=62% | |
233 | BIOCARTA_SEGMENTATION CLOCK | 22 | 0.36 | 0.77 | 0.842 | 0.933 | 1.000 | 1766 | tags=14%, list=9%, signal=15% | |
234 | INOH_CYTOSOLIC CALCIUM ION CONCENTRATION ELEVATION (THROUGH IP3 RECEPTOR) | 14 | 0.40 | 0.76 | 0.819 | 0.934 | 1.000 | 1188 | tags=29%, list=6%, signal=30% | |
235 | BIOCARTA_THE 41BB-DEPENDENT IMMUNE RESPONSE | 13 | 0.41 | 0.76 | 0.778 | 0.932 | 1.000 | 2867 | tags=31%, list=15%, signal=36% | |
236 | BIOCARTA_ROLE OF MAL IN RHO-MEDIATED ACTIVATION OF SRF | 17 | 0.38 | 0.76 | 0.828 | 0.932 | 1.000 | 1189 | tags=24%, list=6%, signal=25% | |
237 | NETPATH_FLK2_FLT3 | 16 | 0.38 | 0.75 | 0.840 | 0.944 | 1.000 | 932 | tags=13%, list=5%, signal=13% | |
238 | REACTOME_CITRIC_ACID_CYCLE__TCA_CYCLE_ | 12 | 0.40 | 0.73 | 0.824 | 0.958 | 1.000 | 2435 | tags=25%, list=13%, signal=29% | |
239 | REACTOME_PYRUVATE_METABOLISM_AND_TCA_CYCLE | 17 | 0.37 | 0.73 | 0.851 | 0.954 | 1.000 | 2435 | tags=29%, list=13%, signal=34% | |
240 | BIOCARTA_ENDOCYTOTIC ROLE OF NDK PHOSPHINS AND DYNAMIN | 14 | 0.38 | 0.73 | 0.857 | 0.953 | 1.000 | 2039 | tags=29%, list=11%, signal=32% | |
241 | HUMANCYC_TCA CYCLE VARIATION III (EUKARYOTIC) | 16 | 0.36 | 0.72 | 0.874 | 0.958 | 1.000 | 2435 | tags=25%, list=13%, signal=29% | |
242 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 12 | 0.38 | 0.71 | 0.876 | 0.965 | 1.000 | 3242 | tags=33%, list=17%, signal=40% | |
243 | BIOCARTA_ION CHANNELS AND THEIR FUNCTIONAL ROLE IN VASCULAR ENDOTHELIUM | 41 | 0.30 | 0.71 | 0.960 | 0.964 | 1.000 | 2455 | tags=10%, list=13%, signal=11% | |
244 | REACTOME_COMMON_PATHWAY | 11 | 0.38 | 0.70 | 0.876 | 0.969 | 1.000 | 2455 | tags=9%, list=13%, signal=10% | |
245 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 12 | 0.38 | 0.70 | 0.867 | 0.965 | 1.000 | 1448 | tags=17%, list=8%, signal=18% | |
246 | HUMANCYC_FATTY ACID BETA-OXIDATION I | 16 | 0.35 | 0.70 | 0.917 | 0.963 | 1.000 | 808 | tags=13%, list=4%, signal=13% | |
247 | BIOCARTA_PLATELET AMYLOID PRECURSOR PROTEIN PATHWAY | 13 | 0.37 | 0.69 | 0.896 | 0.963 | 1.000 | 4396 | tags=31%, list=24%, signal=40% | |
248 | HUMANCYC_PHOSPHOLIPASES | 22 | 0.32 | 0.69 | 0.954 | 0.960 | 1.000 | 736 | tags=5%, list=4%, signal=5% | |
249 | REACTOME_CLASS_B_2__SECRETIN_FAMILY_RECEPTORS_ | 23 | 0.32 | 0.69 | 0.935 | 0.959 | 1.000 | 5118 | tags=30%, list=27%, signal=42% | |
250 | INOH_G ALPHA I GDP-GTP EXCHANGE SIGNALING | 36 | 0.29 | 0.68 | 0.975 | 0.960 | 1.000 | 50 | tags=3%, list=0%, signal=3% | |
251 | REACTOME_GAMMA_CARBOXYLATION__TRANSPORT__AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | 10 | 0.37 | 0.67 | 0.917 | 0.964 | 1.000 | 4861 | tags=30%, list=26%, signal=41% | |
252 | REACTOME_EGFR_DOWNREGULATION | 10 | 0.32 | 0.55 | 0.974 | 0.997 | 1.000 | 4005 | tags=40%, list=22%, signal=51% | |
253 | BIOCARTA_CARDIAC PROTECTION AGAINST ROS | 11 | 0.26 | 0.47 | 0.998 | 0.998 | 1.000 | 4092 | tags=18%, list=22%, signal=23% |